Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Diabetes Management 2019

About Conference


With the amalgamation of peerless speakers of Diabetes Conferences, Conference Series LLC is privileged to announce its " International Conference on Diabetes Complication and Management (Diabetes Management 2019)”,  which is to be held in Brisbane, Australia on November 14-15, 2019. Diabetes Management program focuses on “Unite for diabetes - Precautions and Preventions for a Diabetes free world”. In collaboration with its Editorial Board Members along with institutional partners the Diabetes Management  includes various people presenting their research in the form of  Keynote speeches,  Oral Presentations, Video presentations, Symposia, Workshops, Poster Presentations, E-Posters and Exhibitions covering a range of topics and important issues which may be helpful for us all from the research to the practical implementations.
 
Why to attend Diabetes Management Conference?
The Diabetes Management Conference will  act as a platform the Academic Scientists, Leading Endocrinologists, Diabetician, Surgeons, Primary Health care specialists, Paediatricians, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe where all the aspects of Endocrinology, Diabetes Mechanism, Disorders and Treatment will be discussed under single roof.
Commonness of Complications in Diabetes are expanding among all ages in Asia generally because of increments in overweight and corpulence, undesirable eating routine and physical latency. There are around 60 million individuals with Diabetes in the European and Asia-Pacific Region, or around 10.3% of men and 9.6% of ladies matured 25 years and over.
 
Medical doctors, health care providers consider the prevention of Diabetes diseases as an essential tool to improve the general health status of the population. The proportions of people suffering from the disease are expected to increase in future according to a recent statistical survey. Realizing this imperative, Conference Series LLC  is set to organize Diabetes Management 2019 for the upcoming year with a view to enhance research and promote awareness. 
 
Conference Opportunities at Diabetes Management Conference Event:
For Universities, Associations & Societies:
  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation
For Business Delegates:
  • Speaker Presentations
  • Symposium hosting
  • Book Launch event
  • Networking opportunities
  • Audience participation
For Product Manufacturers:
  • Exhibitor and Vendor Booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering
  • Marketing and Networking with clients
For Students and Research Scholars:
Diabetes Management Conference Important Links:
Diabetes Management Conference Scientific Program
Questions.....?
General Queries: diabetesmanagement@conferencesseries.org
Registration Queries: diabetesmanagement@conferenceint.com
Contact us at: UK  - +44-203-7690-972
 
Connect with the International Platform of Research from your Door Step!
Video is the easiest way to present the most complicated research in powerful narrative way.
What is Virtual/Video Presentation?
We believe in providing an equal opportunity to underdeveloped, developing and developed country to join the international platform from any corner of the world.
 
So, Conference series LLC Ltd. designed Virtual/ Video Presentation platform by so that researcher can present their latest research in front of elite researcher and scientist. This platform will also provide researchers to get feedback and ideas from the people working on the same domain.
Why Virtual/ Video Presentation?
A video presentation has ability to engage the audience easily. Detail video presentation support in presenting the complex research in a very easy and understandable manner.
Till now 2000+ speakers joined us from all across the world through Virtual/ Video Presentation.
Video Presentation Opportunity:
We suggest the participant to join the conference through video presentation in following condition:
  • No Travel Plan & Agreements
  • No Visa Issues
  • Busy Schedule
  • Schedule Conflict
Benefits of opting Video Presentation:
  • Speaker video presentation will be officially recognized
  • One of the scientific committee will represent the presentation on behalf of speaker
  • Session Chair suggestions and comments will be communicated after the conference
  • Publication of Abstract in the Souvenir and International Journal with unique DOI
  • Certification by the International Organizing Committee (IOCM)
  • Conference Souvenir (Hardcopy) delivery to presenter address
  • The presentation will be added on our You tube channel
  • Details for Video Presenter:
  • Record your presentation video
  • Duration of the video: 20 -25 minutes
  • Registration Fee: $249
 
Procedure:
Download the abstract format (Download Abstract template here)
Submit you’re abstract in the prescribed format via email or online : https://diabetesmanagement.conferenceseries.com/abstract-submission.php
Submit your presentation through www.wetransfer.com                
Video Presentation Club @ Diabetes Management 2019, Brisbane, Australia
 

Diabetes Management 2019

Why Diabetes Management 2019?
  • Poster and Paper presentations and world-class Exhibitions.
  • Opportunities to gain a deeper understanding of the topic.
  • Intensifying  Interactive knowledge.
  • Meet Academics and Industrial professionals to get inspired.
  • Great credits for the work in progress.
  • Valuable talks and symposiums from renowned speakers.
  • Meaningful sessions and accomplishments
With members from over the world focused on learning about Diabetes, about its complications and how to manage; this is your best opportunity to reach the largest assemblage of participants from the Diabetes Association community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new advancements and developments in Infectious Diseases, and receive name recognition at this 2-days event.
 
Target Audience @ Diabetes Management 2019:
  • Academic researcher
  • Endocrinologists
  • Diabetologists
  • Data management companies
  • Medical colleges
  • Training institute
  • Diabetes Societies & Association
  • Medical & Pharmacy Companies
  • Software development companies
  • Business entrepreneurs
Manufacture medical devices & companies
  • Health Care Associations & Societies
  • Medical & Pharmacy Companies
  • Medical Devices and drug Manufacturing Companies
  • Laboratory Technicians and Diagnostic Companies
  • Business Entrepreneurs and Industrialists

Abstract Topics

Track 1: Type 1 Diabetes
 Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin. Insulin is a hormone needed to allow sugar (glucose) to enter cells to produce energy.Different factors, including genetics and some viruses, may contribute to type 1 diabetes. Although type 1 diabetes usually appears during childhood or adolescence, it can develop in adults.Despite active research, type 1 diabetes has no cure. Treatment focuses on managing blood sugar levels with insulin, diet and lifestyle to prevent complications
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 2: Type 2 Diabetes
Diabetes Type 2 is seen is elderly and kids which is a common type of diabetes seen and is not inherited from any genetic disorder. Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. It is diagnosed when the pancreas does not produce enough insulin (reduced insulin production) and/or the insulin does not work effectively and/or the cells of the body do not respond to insulin effectively (known as insulin resistance)
 
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
 
Track 03: Complications associated with Diabetes
The term diabetes mellitus describes several diseases of abnormal carbohydrate metabolism that are characterized by hyperglycaemia. It is associated with a relative or absolute impairment in insulin secretion, along with varying degrees of peripheral resistance to the action of insulin. They are derived after doing many clinical trials on animal models. Every few years, the diabetes community revaluates the current recommendations for the classification, diagnosis, and screening of diabetes, reflecting new information from research and clinical practice which in turns help in understanding current prevention and treatment options and cost effectiveness in treatment and prevention of Diabetes.
 
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 04: Diabetes Complications: Human Organs
Diabetes affects almost all the organs in humans. It severely affects the Cardiovascular System and the Urinary system. Also it affects nervous system. Retinopathy is caused by blood vessels in the back of the eye (the retina) swelling and leaking. High blood pressure is also a contributing factor for diabetic retinopathy.Diabetes contributes to high blood pressure and is linked with high cholesterol which significantly increases the risk of heart attacks and cardiovascular disease.Damage to the kidneys takes place over a period of years and can picked up by nephropathy screening before it gets too serious.The presence of nerve damage (neuropathy) is commonly noticed.An alternative cause of disturbed digestion can be the result of diabetes medication.
 
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 05: Paediatric Diabetes
Diabetes is a chronic disease and its management is associated with multiple challenges. The difficulty is more pronounced in the paediatric age group who has various requirements related to their growth and development. Factors that contribute to difficulties in managing diabetes in children include their status of growth and development, psychological characteristics and social behavior, health status in terms of diabetes control, family dynamics (including life style, socio economic status, and cultural beliefs), and care at nursery and school settings.
 
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 06: Dermatological Complications
Patients with type 2 diabetes more often develop skin infections, whereas those with type 1 more often have autoimmune-related lesions.Insulin signaling supports normal skin proliferation, differentiation, and maintenance, and a lack of insulin may lead to impaired wound healing, which may affect insulin resorption. Skin manifestations of diabetes may also serve as ports of entry for secondary infection.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 07: Diabetic ketoacidosis
Diabetic ketoacidosis is characterized by a serum glucose level greater than 250 mg per dL, a pH less than 7.3, a serum bicarbonate level less than 18 mEq per L, an elevated serum ketone level, and dehydration. DKA results from insulin deficiency from new-onset diabetes, insulin noncompliance, prescription or illicit drug use, and increased insulin need because of infection .This insulin deficiency stimulates the elevation of the counter regulatory hormones (glucagon, catecholamines, cortisol, and growth hormone). Without the ability to use glucose, the body needs alternative energy sources.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 08: Diabetic retinopathy
Diabetic retinopathy progresses from mild nonproliferative abnormalities, characterized by increased vascular permeability, to moderate and severe nonproliferative diabetic retinopathy (NPDR), characterized by vascular closure, to proliferative diabetic retinopathy (PDR), characterized by the growth of new blood vessels on the retina and posterior surface of the vitreous. Macular edema, characterized by retinal thickening from leaky blood vessels, can develop at all stages of retinopathy. Pregnancy, puberty, blood glucose control, hypertension, and cataract surgery can accelerate these changes.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 09: Microvascular Complications
Diabetes milletus associated microvascular complications appear particularly at higher risk of accelerated atherosclerosis which ultimately culminates in cerebrovascular and cardiovascular events and premature death. Micro vessels are the basic functional unit of the cardiovascular system comprising of arterioles, capillaries, and venules. They differ from macro vessels in both their architecture and cellular components. In contrast to macrovessels supplying blood to organs, microvessels play important roles in maintaining blood pressure and proper nutrient delivery. The microcirculation also has regulatory systems controlling vascular permeability and myogenic responses that can adapt blood flow according to local metabolic needs.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 10: Gestational diabetes
Gestational diabetes is a type of diabetes that is first seen in a pregnant woman who did not have diabetes before she was pregnant. Some women have more than one pregnancy affected by gestational diabetes. Gestational diabetes usually shows up in the middle of pregnancy. Doctors most often test for it between 24 and 28 weeks of pregnancy.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 11: Gastroparesis
Gastroparesis is a serious complication of diabetes mellitus (DM), defined as a delay in gastric emptying without any mechanical obstruction in the stomach. Other non-diabetic causes of gastroparesis are surgery, neurologic disorders, medication and idiopathic causes;however, the outcomes for those with diabetic gastroparesis (DGP) are worse. This disorder causes a huge morbidity burden as well as significantly impairing glucose control.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
Track 12: New Insulins: Benefits and Challenges
Insulin degludec seemed to demonstrate a reduction in episodes of hypoglycemia, especially nocturnal hypoglycemia, by approximately 25% compared with insulin glargine, the FDA in its assessment highlighted the fact that this benefit was not a consistent feature seen across the different types of diabetes or definitions of hypoglycemia, in particular the more objective definitions of hypoglycemia .B enefits include flexibility of timing of insulin administration, the lack of weight gain or even weight loss, and some improvement in quality-of-life aspects.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 13: Diabesity Management: The Role of Structured Nutritional Therapy
The global prevalence of "diabesity"-diabetes related to obesity-is increasing steadily over the past few decades because of the obesity epidemic. Although bariatric surgery is an effective treatment option for patients with diabesity, its limited availability, invasiveness, relatively high costs and the potential for surgical and postsurgical complications restrict its widespread use. Therefore, medical management is the only option for a majority of patients with diabesity. Diabetes control with several anti-diabetic agents, including insulin, causes weight gain with probability of worsening diabesity. Rational use of anti-diabetic medications with weight loss potential in varying combinations may help to address this key issue for long-term management of diabesity. 
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 14: Footcare in Diabetes
The  large multi-centre RCT investigating a dressing that for the first time, according to the manufacturer, generates a sustained release of nitric oxide (NO) on the wound. For this study they recruited patients from 10 diabetic foot clinics across the UK. To be included, patients needed to have a superficial DFU of >2.5cm2 and a palpable pulse or ankle brachial index (ABI) >0.5.Patients were then randomized (by computer) to receive the NO dressing every 2 days (intervention group) or receive a dressing chosen by their treating clinician as often as they needed (control group).
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
 
Track 15: Insulin Pump Therapy from Pregnancy to Delivery
The insulin pump should be given stress that pump use in pregnancy is most successful with a motivated receiver and the involvement of a multidisciplinary team that includes a diabetologist, obstetrician, specialised diabetes nurse, midwife and dietician. If switching prior to pregnancy, most specialists would advocate pump use for at least 3 months before attempting to conceive, in order to achieve stable blood glucose levels and become adept at using the pump. However, it is possible to start a pump during pregnancy if needed.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 16: Drug Induced Hyper & Hypo glycemia
Drug-induced serum glucose alterations manifested as hyperglycemia or hypoglycemia and ranging from mild to moderate to severe symptoms either appearing acutely or chronically, have perpetual effects on the body, particularly in patients with diabetes. This article and a second one that will appear in the next issue of this journal review drug-induced serum glucose alterations in a two-part series. In this article, we review pertinent clinical information on the incidence of drug-induced hypoglycemia and discuss the underlying pathophysiological mechanisms involved.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
Track 17: Biomarkers for Diabetes
Diabetes is a growing global metabolic epidemic. Current research is focussing on exploring how the biological processes and clinical outcomes of diabetes are related and developing novel biomarkers to measure these relationships, as this can subsequently improve diagnostic, therapeutic and management capacity. The most promising research avenue identified is the detection and quantification of micro RNA. Further, the utilisation of functionalised electrodes as a means to detect biomarker compounds also warrants attention. Biomarkers have also been used to study Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling .
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
 
Track 18: Stem Cell therapy for Diabetes
Scientists working to develop more effective treatments for diabetes are turning to stem cells. Such cells can be transformed into cells that produce insulin, the hormone that controls blood sugar.Restoration of insulin independence and normoglycemia has been the overarching goal in diabetes research and therapy. While whole-organ and islet transplantation have become gold-standard procedures in achieving glucose control in diabetic patients, the profound lack of suitable donor tissues severely hampers the broad application of these therapies. Here, we describe current efforts aimed at generating a sustainable source of functional human stem cell-derived insulin-producing islet cells for cell transplantation and present state-of-the-art efforts to protect such cells via immune modulation and encapsulation strategies.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
 
Track 19: Advanced Technologies & Treatments for Diabetes
Blood glucose (blood sugar) monitoring is the main tool you have to check your diabetes control. This check tells you your blood glucose level at any one time. The artificial pancreas bridges the gap between two pieces of diabetes technology that already exist: the insulin pump and the continuous glucose monitor (CGM). Relatively, a large percentage of world population is affected by diabetes mellitus, out of which approximately 5-10% with type 1 diabetes while the remaining 90% with type 2. Insulin administration is essential for type 1 patients while it is required at later stage by the patients of type 2. Current insulin delivery systems are available as transdermal injections which may be considered as invasive. Several non-invasive approaches for insulin delivery are being pursued by pharmaceutical companies to reduce the pain, and hypoglycemic incidences associated with injections in order to improve patient compliance.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan
 
 
Track 20: Herbal and Alternative Remedies
Herbal supplements and remedies are used for the treatment of diabetes and hormonal problems such as estrogen and progesterone levels and treatment for menopausal hormone imbalance, etc. These include:Capsaicin cream, a topical ointment made with cayenne, has been reported by some patients to help lower pain in the hands and feet from diabetic neuropathy.Evening primrose oil is thought to help diabetic nerve pain Ginkgo, garlic, holy basil leaves, fenugreek seeds, ginseng, and hawthorn are other herbals that have been promoted by some as remedies for diabetic symptoms.Alternative treatments include Acupuncture, Natural Dietary Supplements, Plant Foods, Natural Remedies for endocrine disorders, Hormonal imbalance cure by medicinal plants, Effects of Herbals in Male impotence & female infertility, Herbals acts on adrenal glands, Support the Endocrine System with Adaptogen Herbs, Avoid Environmental Toxins.
Related Conferences:
4th International Conference on Metabolic Syndrome June 20-11, 2019 Paris, France; 2nd Global Meeting on Diabetes and Endocrinology May 30-31, 2019 Istanbul, Turkey; 28th European Diabetes Congress June 10-11, 2019 Edinburgh, Scotland; World Congress on Insulin Resistance Diabetes, Endocrinology Metabolism and Nursing July 05-06, 2019 Columbus, USA; 29th World Diabetes & Heart Congress July 24-25, 2019 Melbourne, Australia; 12th International Conference on Diabetes & Metabolism July 29-30, 2019 Chicago, USA; 30th International Congress on Prevention of Diabetes and Complications October 21-22, 2019 Zurich, Switzerland; 21st Asia Pacific Diabetes Conference April 17-18, 2019 Osaka, Japan

 

VISA - TripAdvisor

 

Planning a Trip to Australia?? Attend our Meeting!!!

Issue with VISA!!

Diabetes Management Conference Committee will be happy to help you in all regards to plan your trip to Brisbane, Australia.  Avail the official invitation letter from us to attend this event and ahead with a closer step for approval of your VISA.

Mail to: diabetesmanagement@conferencesseries.org

Market Analysis

We are overwhelmed to announce “International Conference on Diabetes Complication and Management” which is going to be held during November 14-15, 2019 at Brisbane, Australia. The Conference will be organized around the theme “Unite for diabetes - Precautions and Preventions for a Diabetes free world”.
This conference highlights the latest and exciting innovations in Diabetes & its Treatment. Diabetes 2019 Conference invites all renowned scientists, endocrinologists, surgeons, dietitians, radiation therapists, general physicians, primary health care specialists, talented young scientists, pharmaceutical industrial delegates and student communities across the globe to attend International Diabetes congress.
 
Importance & Scope:
 
Millions of people are suffering and also trying all kinds of diets, pills, and treatments to clear their mental fog, to boost energy and lose weight. Unfortunately, they will all fail unless they learn how to heal the underlying Diabetes issues.
Number of people suffering from Diabetes disorders continues to rise each year. As reported by the World Health Organization (WHO), on an average 1 out of every 13 people are diagnosed globally with Diabetes each year and also projects that diabetes will be the 7th leading cause of death in 2030. Around 60% of the populations effected with Diabetes diseases are uncaring of the situation.
Diabetes Meeting 2019 will feature the latest developments in research, diagnosis and prevention of diabetes, new insulin analogues, new technologies and devices for diabetic prevention, obesity and many more. Not only will this innovative conference enhance your practical and theoretical knowledge but also provides you with the unique opportunity to network with a wide range of professionals in the field of diabetes.
 
Global Diabetes Prevalence:
 
The world prevalence of diabetes among adults is 6.4%, affecting 285 million adults in 2010. It will increase to 7.7%, and 439 million adults by 2030. Between 2010 and 2030, there will be a 69% increase in numbers of adults with diabetes in developing countries and a 20% increase in developed countries.
Today’s Market Study of Diabetes in USA | Europe | Middle East | Asia Pacific
Europe: The number of people living with diabetes in Europe is expected to increase from 51 million in 2014 to 67.9 million by 2035, according to the International Diabetes Federation (IDF). Across Europe, around 1 in 11 adults is affected and the number is set to rise as the population ages.
USA: Diabetes Mellitus has been growing at an exponential rate and World Health Organization (WHO) estimates that diabetic population is likely to reach 356 million in 2030. The United States is expected to increase to 102 per cent in the diabetic epidemic in 2030 when compared to 2000
Middle East: The rate of diabetes in Arabian Peninsula is over twice the global average rate and much higher than some other areas of the Middle East and North Africa (MENA).
Asia Pacific: The Asia-Pacific Diabetes Care Devices Market has been estimated at USD 2.521 Billion in 2015 and is projected to reach USD 3.538 billion by 2020, at a CAGR of 7.41% during the forecast period from 2015 to 2020.
Studies show that men have higher rates of diabetes prevalence than women. Women with diabetes are more likely than men with the disease to have poor blood glucose control, be obese, and have high blood pressure and unhealthy cholesterol levels.

 

To Collaborate Scientific Professionals around the World

Conference Date November 14-15, 2019

Speaker Opportunity

Supported By

Journal of Diabetes & Metabolism Journal of Diabetic Complications & Medicine Journal of Obesity & Weight Loss Therapy Journal of the Pancreas

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by